The anticoagulant drug Pradaxa was associated with more patient injuries or deaths than any other regularly monitored drug during the second quarter of 2011, according to a recent report.
The QuarterWatch Report on data collected during Q2 2011, which was released by the Institute for Safe Medicine Practices (ISMP), found that anticoagulant medication, which is intended to reduce the risk of stroke, was a suspect drug that was linked to 856 reported cases of patient injury or death during the quarter. That figure is higher than the number of incidents linked to any other regularly monitored drug, but is also slightly lower than the 931 reports that Pradaxa had been linked to during Q1 2011 in a previous report.
Going further into detail regarding the Pradaxa incidents, in 117 cases the patient died, while 511 cases included some type of hemorrhage. The median age of patients was also found to be 80-years-old, which the ISMP said reinforced the idea that older patients who use Pradaxa were more susceptible to suffering a dangerous bleeding event.